CRISPR in Drug Discovery 2021
Print Print
Presentation
23 March
Wednesday 24 March
DAY 1
Conference HallDAY 2
All times shown are GMT —
DAY 1
Conference HallDAY 2
11:00
Welcome & Introductions
Chairs: Andrew Bassett, Wellcome Sanger Institute  Klio Maratou, GlaxoSmithKline  Marcello Maresca, AstraZeneca  

Welcome & Introductions
11:00 (5 mins)
Andrew Bassett, Wellcome Sanger Institute  Klio Maratou, GlaxoSmithKline  Marcello Maresca, AstraZeneca  
11:00
11:05 11:05
11:10 11:10
11:15 11:15
11:20 11:20
11:25 11:25
11:30 11:30
11:35 11:35
11:40 11:40
11:45 11:45
11:50 11:50
11:55 11:55
12:00 12:00
12:05 12:05
12:10 12:10
12:15 12:15
12:20 Refreshment Break/Poster Session/Vendor Exhibition 12:20
12:25 12:25
12:30 12:30
12:35 12:35
12:40 12:40
12:45 12:45
12:50 12:50
12:55 12:55
13:00 13:00
13:05 13:05
13:10 13:10
13:15 13:15
13:20
Session Chair Welcome
13:20 (5 mins)
Klio Maratou, GlaxoSmithKline  

Therapeutic strategies via genome engineering: new approaches and new challenges
13:25 (20 mins)
Prashant Mali, UCSD  

Deciphering the pathogenicity of cardiac disease-associated genetic variants using human iPSCs and gene editing
13:45 (20 mins)
Richard Davis, Leiden University Medical Center  
13:20
13:25 13:25
13:30 13:30
13:35 13:35
13:40 13:40
13:45 13:45
13:50 13:50
13:55 13:55
14:00 14:00
14:05 14:05
14:10 14:10
14:15 14:15
14:20 Refreshment Break 14:20
14:25 14:25
14:30
Cell engineering at the speed of light
14:30 (20 mins)
Greg Sienski, AstraZeneca  

Joint Q&A Session
14:50 (20 mins)
Prashant Mali, UCSD  Richard Davis, Leiden University Medical Center  Greg Sienski, AstraZeneca  
14:30
14:35 14:35
14:40 14:40
14:45 14:45
14:50 14:50
14:55 14:55
15:00 15:00
15:05 15:05
15:10 15:10
15:15 15:15
15:20 15:20
15:25 Refreshment Break 15:25
15:30 15:30
15:35
Mechanistic Insights into Cytosine and Adenine Base Editors
16:20 (20 mins)
Alexis Komor, UCSD  
15:35
15:40 15:40
15:45 15:45
15:50 15:50
15:55 15:55
16:00 16:00
16:05 16:05
16:10 16:10
16:15 16:15
16:20 16:20
16:25 16:25
16:30 16:30
16:35 16:35
16:40 Refreshment Break 16:40
16:45
Expanding gene-editing tool delivery and targeting range in human cells
16:45 (20 mins)
Manuel Goncalves, LUMC  

Strategies to improve precision and safety of human cells manipulation
17:05 (20 mins)
Claudio Mussolino, University of Freiburg   

Joint Q&A Session
17:25 (20 mins)
Alexis Komor, UCSD  Manuel Goncalves, LUMC  Claudio Mussolino, University of Freiburg   

Modulation of DNA repair pathways by HDR-CRISPR promotes seamless genome editing in primary human hematopoietic cells
17:45 (5 mins)


Modulation of DNA repair pathways by HDR-CRISPR promotes seamless genome editing in primary human hematopoietic cells
17:45 (5 mins)
Antonio Carusillo, Center for Transfusion Medicine and Gene Therapy  

Homology-directed safe harbour insertion of transgenes encoding full-length dystrophin through high-capacity adenoviral vector delivery of CRISPR-Cas9 nucleases and donor DNA
17:50 (5 mins)


What do people think about genetic engineering: a systematic review of post-CRISPR questionnaires
17:55 (5 mins)


Joint Q&A Session
18:00 (5 mins)


Conference Close & Poster Winner Presentations
18:05 (10 mins)

16:45
16:50 16:50
16:55 16:55
17:00 17:00
17:05 17:05
17:10 17:10
17:15 17:15
17:20 17:20
17:25 17:25
17:30 17:30
17:35 17:35
17:40 17:40
17:45 17:45
17:50 17:50
17:55 17:55
18:00 18:00
18:05 18:05
18:10 18:10
18:15 18:15
18:20 18:20
18:25 18:25
18:30 18:30
18:35 18:35
18:40 18:40
18:45 18:45
18:50 18:50
18:55 18:55
19:00 19:00